PIK3CA mutations are associated with lower rates of pathologic complete response to anti-human epidermal growth factor receptor 2 (HER2) therapy in primary HER2-overexpressing breast cancer
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
8 September 2014
|
| In: |
Journal of clinical oncology
Year: 2014, Jahrgang: 32, Heft: 29, Pages: 3212-3222 |
| ISSN: | 1527-7755 |
| DOI: | 10.1200/JCO.2014.55.7876 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1200/JCO.2014.55.7876
|
| Verfasserangaben: | Sibylle Loibl, Gunter von Minckwitz, Andreas Schneeweiss, Stefan Paepke, Annika Lehmann, Mahdi Rezai,Dirk M. Zahm, Peter Sinn, Fariba Khandan, Holger Eidtmann, Karel Dohnal, Clemens Heinrichs, Jens Huober, Berit Pfitzner, Peter A. Fasching, Fabrice Andre, Judith L. Lindner, Christos Sotiriou, August Dykgers, Sanxing Guo, Stephan Gade, Valentina Nekljudova, Sherene Loi, Michael Untch, and Carsten Denkert |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1525549294 | ||
| 003 | DE-627 | ||
| 005 | 20220812155058.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 160217s2014 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1200/JCO.2014.55.7876 |2 doi | |
| 035 | |a (DE-627)1525549294 | ||
| 035 | |a (DE-576)45554929X | ||
| 035 | |a (DE-599)BSZ45554929X | ||
| 035 | |a (OCoLC)1340900216 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Loibl, Sibylle |e VerfasserIn |0 (DE-588)12433024X |0 (DE-627)085790508 |0 (DE-576)294122753 |4 aut | |
| 245 | 1 | 0 | |a PIK3CA mutations are associated with lower rates of pathologic complete response to anti-human epidermal growth factor receptor 2 (HER2) therapy in primary HER2-overexpressing breast cancer |c Sibylle Loibl, Gunter von Minckwitz, Andreas Schneeweiss, Stefan Paepke, Annika Lehmann, Mahdi Rezai,Dirk M. Zahm, Peter Sinn, Fariba Khandan, Holger Eidtmann, Karel Dohnal, Clemens Heinrichs, Jens Huober, Berit Pfitzner, Peter A. Fasching, Fabrice Andre, Judith L. Lindner, Christos Sotiriou, August Dykgers, Sanxing Guo, Stephan Gade, Valentina Nekljudova, Sherene Loi, Michael Untch, and Carsten Denkert |
| 264 | 1 | |c 8 September 2014 | |
| 300 | |a 11 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am16.02.2016 | ||
| 700 | 1 | |a Schneeweiss, Andreas |d 1961- |e VerfasserIn |0 (DE-588)109972554 |0 (DE-627)632849630 |0 (DE-576)327251859 |4 aut | |
| 700 | 1 | |a Sinn, Peter |d 1957- |e VerfasserIn |0 (DE-588)1022590944 |0 (DE-627)717004783 |0 (DE-576)365646342 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of clinical oncology |d Alexandria, Va. : American Society of Clinical Oncology, 1983 |g 32(2014), 29, Seite 3212-3222 |h Online-Ressource |w (DE-627)313116962 |w (DE-600)2005181-5 |w (DE-576)090887018 |x 1527-7755 |7 nnas |a PIK3CA mutations are associated with lower rates of pathologic complete response to anti-human epidermal growth factor receptor 2 (HER2) therapy in primary HER2-overexpressing breast cancer |
| 773 | 1 | 8 | |g volume:32 |g year:2014 |g number:29 |g pages:3212-3222 |g extent:11 |a PIK3CA mutations are associated with lower rates of pathologic complete response to anti-human epidermal growth factor receptor 2 (HER2) therapy in primary HER2-overexpressing breast cancer |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1200/JCO.2014.55.7876 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20160217 | ||
| 993 | |a Article | ||
| 994 | |a 2014 | ||
| 998 | |g 1022590944 |a Sinn, Peter |m 1022590944:Sinn, Peter |d 910000 |d 912000 |e 910000PS1022590944 |e 912000PS1022590944 |k 0/910000/ |k 1/910000/912000/ |p 8 | ||
| 998 | |g 109972554 |a Schneeweiss, Andreas |m 109972554:Schneeweiss, Andreas |d 910000 |e 910000PS109972554 |k 0/910000/ |p 3 | ||
| 999 | |a KXP-PPN1525549294 |e 2898437514 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"id":{"doi":["10.1200/JCO.2014.55.7876"],"eki":["1525549294"]},"physDesc":[{"extent":"11 S."}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"title":[{"title":"PIK3CA mutations are associated with lower rates of pathologic complete response to anti-human epidermal growth factor receptor 2 (HER2) therapy in primary HER2-overexpressing breast cancer","title_sort":"PIK3CA mutations are associated with lower rates of pathologic complete response to anti-human epidermal growth factor receptor 2 (HER2) therapy in primary HER2-overexpressing breast cancer"}],"origin":[{"dateIssuedKey":"2014","dateIssuedDisp":"8 September 2014"}],"relHost":[{"recId":"313116962","physDesc":[{"extent":"Online-Ressource"}],"id":{"zdb":["2005181-5"],"issn":["1527-7755"],"eki":["313116962"]},"title":[{"subtitle":"JCO : an American Society of Clinical Oncology journal","title":"Journal of clinical oncology","title_sort":"Journal of clinical oncology"}],"origin":[{"publisherPlace":"Alexandria, Va. ; Baltimore, Md. [u.a.]","dateIssuedKey":"1983","dateIssuedDisp":"1983-","publisher":"American Society of Clinical Oncology ; Lippincott Williams & Wilkins"}],"part":{"pages":"3212-3222","extent":"11","issue":"29","text":"32(2014), 29, Seite 3212-3222","year":"2014","volume":"32"},"language":["eng"],"note":["Fortsetzung der Druck-Ausgabe","Gesehen am 22.05.23"],"pubHistory":["1.1983 -"],"disp":"PIK3CA mutations are associated with lower rates of pathologic complete response to anti-human epidermal growth factor receptor 2 (HER2) therapy in primary HER2-overexpressing breast cancerJournal of clinical oncology","type":{"bibl":"periodical","media":"Online-Ressource"},"corporate":[{"role":"isb","display":"American Society of Clinical Oncology"}],"titleAlt":[{"title":"official journal of the American Society of Clinical Oncology"},{"title":"JCO"},{"title":"Journal of clinical oncology legacy archive (ASCO)"}]}],"language":["eng"],"name":{"displayForm":["Sibylle Loibl, Gunter von Minckwitz, Andreas Schneeweiss, Stefan Paepke, Annika Lehmann, Mahdi Rezai,Dirk M. Zahm, Peter Sinn, Fariba Khandan, Holger Eidtmann, Karel Dohnal, Clemens Heinrichs, Jens Huober, Berit Pfitzner, Peter A. Fasching, Fabrice Andre, Judith L. Lindner, Christos Sotiriou, August Dykgers, Sanxing Guo, Stephan Gade, Valentina Nekljudova, Sherene Loi, Michael Untch, and Carsten Denkert"]},"note":["Gesehen am16.02.2016"],"recId":"1525549294","person":[{"role":"aut","family":"Loibl","given":"Sibylle","display":"Loibl, Sibylle"},{"display":"Schneeweiss, Andreas","given":"Andreas","role":"aut","family":"Schneeweiss"},{"role":"aut","family":"Sinn","given":"Peter","display":"Sinn, Peter"}]} | ||
| SRT | |a LOIBLSIBYLPIK3CAMUTA8201 | ||